Status:
WITHDRAWN
The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection
Lead Sponsor:
Mayo Clinic
Conditions:
Clostridioides Difficile Infection
Eligibility:
All Genders
18+ years
Brief Summary
The study is being done to identify types of bacteria associated with the lining of the large intestine in people who have recently been diagnosed with C. difficile infection to determine if there are...
Detailed Description
Patients who were recently diagnosed with C. difficile infection will undergo assessment of both before treatment and after completing treatment to study the presence of C. difficile in the colonic mu...
Eligibility Criteria
Inclusion
- Adults aged 18 and over
- Confirmed C. difficile infection based on positive C. difficile toxin PCR testing and clinical evidence of diarrhea
Exclusion
- Known active pregnancy
- Prior diagnosis of C. difficile infection within 2 months of this diagnosis
- Other known active gastrointestinal infectious process
- Vulnerable adults
- Any other disease(s), condition(s) or habit(s) that would interfere with completion of study, or in the judgment of the investigator would potentially interfere with compliance to this study or would adversely affect study outcomes
Key Trial Info
Start Date :
September 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04679324
Start Date
September 23 2019
End Date
August 10 2022
Last Update
November 29 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.